Integrated academic health system in New York and Florida
The FDA has cleared four blood tests to help diagnose Alzheimer's in people with memory problems, a move that could speed access to therapies. Experts caution that tests are not for asymptomatic individuals, and many questions remain about accuracy. Readers are advised to focus on brain-healthy risks like blood pressure, diabetes and smoking.
Lawsuits allege GLP-1 diabetes drugs may cause nonarteritic anterior ischemic optic neuropathy (NAION), an eye condition that can cause permanent vision loss. Novo Nordisk and Eli Lilly dispute the claims as regulators review data; meanwhile trials and studies show mixed signals about risk.
This article synthesizes AP News and Independent reporting on U.S. organ transplantation. It highlights how patients struggle to understand options, the variability among hospitals, and the push for patient-friendly tools to compare waiting times, organ offers, and hospital performance. About 100,000 people await transplants while more than 49,000 transplants were performed last year.